- Announced that it continues to advance the deployment of its BioCloud technology
- Initiated the CE standards approval process and BioCloud now has the appropriate power supply ratings for European applications
- In the process of establishing a viral/pathogen advisory committee that will work with management to accelerate various BioCloud applications
- “We are pleased with the progress we are making with our distribution network, our direct customers and various levels of Government,” says Paul Ghezzi, CEO. “Through our growing distribution network, we have been presented with numerous potential customers applications. Most recently we have reviewed various applications for professional and amateur sports.”
TORONTO, ON / January 20, 2021 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it continues to advance the deployment of its BioCloud technology.
“We are pleased with the progress we are making with our distribution network, our direct customers and various levels of Government,” says Paul Ghezzi, CEO. “Through our growing distribution network, we have been presented with numerous potential customers applications. Most recently we have reviewed various applications for professional and amateur sports.”
Non-Disclosure Agreement (NDA)
BioCloud has entered into a Non-Disclosure Agreement, with a leading medical sports authority, to share the full scope of BioCloud’s patents and research. The purpose of the NDA is to advance various potential sport applications. Such applications include, but are not limited to, dressing rooms and training facilities.
BioCloud European Standards
Kontrol has initiated the CE standards approval process and BioCloud now has the appropriate power supply ratings for European applications, which is an important prerequisite for European sales. As part of the product requirements for each country within the European Union there may be further standards approval required but these will be dealt with on a case-by-case basis.
Distribution Network
Kontrol has recently added a South Korean firm to its growing distribution network and is in discussion with numerous interested parties.
Viral/Pathogen Advisory Committee
Kontrol is in the process of establishing a viral/pathogen advisory committee that will work with management to accelerate various BioCloud applications. Kontrol seeks to establish the committee in February 2021.
Corporate Name Change
Kontrol’s corporate name change to Kontrol Technologies Corp. is anticipated to be completed by the end of January 2021. There has been no specific delay in the process other than the time it takes to complete filings between B.C. and Ontario corporate registries and all of the associated requirements.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
Read More: https://agoracom.com/ir/KontrolEnergy/forums/discussion/topics/753445-kontrol-advances-biocloud-technology-for-european-sales-and-provides-update/messages/2299011#message
